Cited by 296Viral-associated cancers and disordersIgG4-Related and Inflammatory DiseasesLymphadenopathy Diagnosis and Analysis

The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.

Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV ‐8‐negative multicentric Castleman disease

Open access

Iwaki, Noriko, Fajgenbaum, David C., Nabel, Christopher S., Gion, Yuka, Kondo, Eisei, Kawano, Mitsuhiro, Masunari, Taro, Yoshida, Isao, Moro, Hiroshi, Nikkuni, Koji, Takai, Kazue, Matsue, Kosei, Kurosawa, Mitsutoshi, Hagihara, Masao, Saito, Akio, Okamoto, Masataka, Yokota, Kenji, Hiraiwa, Shinichiro, Nakamura, Naoya, Nakao, Shinji, Yoshino, Tadashi, Sato, Yasuharu·2016·American Journal of Hematology

DOI 10.1002/ajh.24242

Open this paper in CoChat — free account Open PDF

Abstract

Multicentric Castleman disease (MCD) describes a heterogeneous group of disorders involving systemic inflammation, characteristic lymph node histopathology, and multi‐organ dysfunction because of pathologic hypercytokinemia. Whereas Human Herpes Virus‐8 (HHV‐8) drives the hypercytokinemia in a cohort of immunocompromised patients, the etiology of HHV‐8‐negative MCD is idiopathic (iMCD). Recently, a limited series of iMCD cases in Japan sharing a constellation of clinical features, including thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis (R), and organomegaly (O) has been described as TAFRO syndrome. Herein, we report clinicopathological findings on 25 patients (14 males and 11 females; 23 Japanese‐born and two US‐born), the largest TAFRO syndrome case series, including the first report of cases from the USA. The median age of onset was 50 years old (range: 23–72). The frequency of each feature was as follows: thrombocytopenia (21/25), anasarca (24/25), fever (21/25), organomegaly (25/25), and reticulin fibrosis (13/16). These patients frequently demonstrated abdominal pain, elevated serum alkaline phosphatase levels, and acute kidney failure. Surprisingly, none of the cases demonstrated marked hypergammoglobulinemia, which is frequently reported in iMCD. Lymph node biopsies revealed atrophic germinal centers with enlarged nuclei of endothelial cells and proliferation of endothelial venules in interfollicular zone. 23 of 25 cases were treated initially with corticosteroids; 12 patients responded poorly and required further therapy. Three patients died during the observation period (median: 9 months) because of disease progression or infections. TAFRO syndrome is a unique subtype of iMCD that demonstrates characteristic clinicopathological findings. Further study to clarify prognosis, pathophysiology, and appropriate treatment is needed. Am. J. Hematol. 91:220–226, 2016. © 2015 Wiley Periodicals, Inc.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/ajh.24242

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
Kanda, Y. (2012) · Bone Marrow Transplantation · doi:10.1038/bmt.2012.244 · Cited by 18,876
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
European consensus on grading bone marrow fibrosis and assessment of cellularity.
Thiele, J., Kvasnicka, H. M., Facchetti, F., Franco, V., van der Walt, J. D., & Orazi, A. (2005) · PubMed · Cited by 762
Interleukin-6 is a potent thrombopoietic factor in vivo in mice
Ishibashi, T., Kimura, H., Shikama, Y., Uchida, T., KARIYONE, S., Hirano, T., Kishimoto, T., Takatsuki, F., & Akiyama, Y. (1989) · Blood · doi:10.1182/blood.v74.4.1241.1241 · Cited by 431
High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.
Oksenhendler, E., Boulanger, E., Galicier, L., Du, M., Dupin, N., Diss, T., Hamoudi, R., Daniel, M., Agbalika, F., Boshoff, C., et al. (2002) · Blood · doi:10.1182/blood.v99.7.2331 · Cited by 421
Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro.
Ishibashi, T., Kimura, H., Uchida, T., KARIYONE, S., Friese, P., & Burstein, S. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5953 · Cited by 406
A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients.
Frizzera, G., Peterson, B. A., Bayrd, E. D., & Goldman, A. I. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.9.1202 · Cited by 380
Surgery in Castleman's Disease
Talat, N., Belgaumkar, A. P., & Schulte, K. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e318249dcdc · Cited by 358
HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy
Fajgenbaum, D. C., van Rhee, F., & Nabel, C. S. (2014) · Blood · doi:10.1182/blood-2013-12-545087 · Cited by 336
Self-citation
An Interleukin‐6–Related Systemic Inflammatory Syndrome in Patients Co‐Infected with Kaposi Sarcoma–Associated Herpesvirus and HIV but without Multicentric Castleman Disease
Uldrick, T. S., Wang, V., O’Mahony, D., Aleman, K. O., Wyvill, K. M., Marshall, V. A., Steinberg, S. M., Pittaluga, S., Marić, I., Whitby, D., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/654798 · Cited by 304

Flagged first, then by citations

Show all 39 references

1 of the 39 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

Gessain A., 1997, [Human herpesvirus 8 and associated diseases: Kaposi's sarcoma, body cavity based, Bull Acad Natl Med, 181, 1023
Takai K, 2010, Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural, Rinsho Ketsueki, 51, 320

Sorted by citations

Items 201–296 of 296

Potential stratification of TAFRO syndrome by anti-SS-A antibodies status and therapeutic response to rituximab
Suzuki, T., Yamada, S., Toriumi, K., Kono, M., Tsuchiya, H., & Fujio, K. (2026) · RMD Open · doi:10.1136/rmdopen-2025-006547 · Cited by 2
Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman disease
Talaulikar, D., Ng, J. Y., Bryant, A., Bosco, A. A., Caterson, H. C., Giri, P., Hissaria, P., Harrison, S. J., Lade, S., Leslie, C., et al. (2026) · Internal Medicine Journal · doi:10.1111/imj.70460 · Cited by 2
Idiopathic multicentric Castleman disease: pathogenesis, clinical presentation and recommendations for treatment based on the Castleman Disease Collaborative Network (CDCN)
Ostrowska, B., Romejko‐Jarosińska, J., Domańska‐Czyż, K., & Walewski, J. A. (2021) · Acta Haematologica Polonica · doi:10.5603/ahp.2021.0005 · Cited by 2
Histopathologic findings of TAFRO syndrome with immunohistochemical analysis of the kidney specimen: A case report
Sato, T., Ono, Y., Matsushima, J., Fujii, A., Sato, Y., Hidaka, Y., Kawamoto, S., Yoshino, A., Takeda, T., Ueda, Y., et al. (2021) · Human Pathology Case Reports · doi:10.1016/j.ehpc.2020.200471 · Cited by 2
Self-citation
An Immunocompetent HIV-Negative Elderly Patient with Low-Grade Fever, Generalized Lymphadenopathy, Splenomegaly, and Acute Phase Response: Do Not Forget Castleman Disease
Azariadis, K., Ιωάννου, Μ., Zachou, K., & Dalekos, G. Ν. (2021) · Case Reports in Infectious Diseases · doi:10.1155/2021/6614208 · Cited by 2
TAFRO syndrome treated effectively with corticosteroids: A case report and review of the literature
Sözel, H., & Avşar, E. (2021) · Indian Journal of Nephrology · doi:10.4103/ijn.ijn_520_20 · Cited by 2
Idiopathic multicentric Castleman disease in children: a single-center retrospective analysis
Du, J., Yao, J., Ma, H., Li, L., Wei, A., Zhang, L., Wang, D., Li, Z., Zhang, R., & Wang, T. (2025) · BMC Pediatrics · doi:10.1186/s12887-024-05347-0 · Cited by 3
TAFRO syndrome complicated with occlusion of multiple cerebral arteries
Iwasaki, T., Nakamura, Y., Nakayama, S., Koita, N., Maki, T., Iemura, Y., Haga, H., Okada, T., Akizuki, S., Kuramoto, N., et al. (2018) · Modern Rheumatology Case Reports · doi:10.1080/24725625.2018.1469819 · Cited by 2
Multiple haemangiomas in TAFRO syndrome with atypical features of glomeruloid and epithelioid haemangiomas
Nakamura, Y., Iwamoto, K., Fujisawa, Y., Okiyama, N., Watanabe, R., Ishitsuka, Y., Maruyama, H., Ishii, Y., Kondo, Y., Sakashita, S., et al. (2018) · European Journal of Dermatology · doi:10.1684/ejd.2018.3293 · Cited by 2
Peripheral hypothyroidism and TAFRO syndrome: Particularity of management
M’BALLOU, C., Mennani, F. E., AHMED, B., SANA, R., Ghizlane, E. M., & Nawal, E. A. (2023) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2023.17.2.0300 · Cited by 1
TAFRO Syndrome on 18F-FDG-PET/CT: An Appealing Diagnostic Tool
Jaafari, A., Taheri, N., Mansour, S., Bouhali, S.-E. E., & Attou, R. (2024) · Diagnostics · doi:10.3390/diagnostics14101025 · Cited by 1
Dysmorphic megakaryocytes in TAFRO syndrome: A case series from a single institute
Maida, S., Nakagawa, H., Ureshino, H., Kajihara, K., Yamazaki, S., & Ichinohe, T. (2024) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2024.102870 · Cited by 2
Myelodysplastic neoplasms with repeating TAFRO syndrome-like symptoms
Hayashino, K., Fujii, N., Nagano, T., Ikeda, D., Fujiwara, K., Hashida, R., Kitamura, W., Kobayashi, H., Kondo, T., Seike, K., et al. (2025) · International Journal of Hematology · doi:10.1007/s12185-025-03937-x · Cited by 1
Prognostic value of serum C-reactive protein in idiopathic multicentric Castleman disease and construction of a prognostic model for patients
Lei, Z., Wang, Y. Q., Yu, T., Zhang, Y., Cui, W., Luo, C., Luo, Q., Zhou, L., Gao, Y., & Li, Y. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1544250 · Cited by 1
Tafro syndrome: early combination therapy outcomes and prolonged thrombocytopenia—a seven-case series
Ono, S., Nakamura, T., Nishimura, N., Matsuoka, H., Yoneima, R., Kawashima, H., Miyamoto, M., Matsubara, M., Yada, N., & Yoshimoto, K. (2025) · Modern Rheumatology · doi:10.1093/mr/roaf092 · Cited by 1
A Placebo-Controlled Exploratory Trial of Sirolimus for Tocilizumab-Resistant Idiopathic Multicentric Castleman Disease: Early Termination and Long-Term Extension Results Based on Descriptive Results From Two Patients
Koga, T., Sumiyoshi, R., Shimizu, T., Hosogaya, N., Fukushima, C., Yamamoto, H., Yoshifuji, H., Higa, S., & Kawakami, A. (2025) · Cureus · doi:10.7759/cureus.98233 · Cited by 1
Ruxolitinib in relapsed/refractory TAFRO syndrome: a report of two cases, including one positive for Epstein–Barr virus, and a literature review
Kawajiri, A., Takenaka, K., Narumi, Y., Tsukita, M., Shibuya, R., HASHIMOTO, Y., & Yamamoto, J. (2026) · International Journal of Hematology · doi:10.1007/s12185-025-04147-1 · Cited by 1
How I diagnose Castleman disease
Laczko, D. I., Pillai, V., Frank, D. M., Brandstadter, J. D., & Fajgenbaum, D. C. (2025) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaf147 · Cited by 1
Self-citation
TAFRO syndrome complicating Sjögren’s disease: response to subcutaneous tocilizumab
Ruíz, N. A. U., Murillo–Baquero, N., Camacho, A. F. V., Santiago-Pacheco, V., Taborda-Murillo, A., Muñoz-Vahos, C. H., Naranjo, L. A. G., & Vanegas-García, A. L. (2026) · Clinical Rheumatology · doi:10.1007/s10067-026-08075-1 · Cited by 1
Integrated Bulk and Spatial Proteomics of Castleman Disease: Molecular Signatures Across Subtypes and Compartmentalized Pathogenic Networks in Idiopathic Multicentric Castleman disease (iMCD)–Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Dysfunction, and Organomegaly (TAFRO)
Zheng, S., Huang, Y., Huang, X., Li, S., Zhang, W., Yang, Z., & Cao, Q. (2026) · Modern Pathology · doi:10.1016/j.modpat.2026.101071 · Cited by 1
A Case of TAFRO Syndrome With Pulmonary Abnormalities
Sato, H., Okada, F., Baba, H., Itaya, T., Kashiwagi, J., Asayama, Y., Nawata, T., Yamaguchi, N., Suzuki, T., & Urabe, S. (2021) · Journal of Thoracic Imaging · doi:10.1097/rti.0000000000000616 · Cited by 1
Case report: Importance of early and continuous tocilizumab therapy in nephrotic syndrome associated with idiopathic multicentric Castleman disease: A case series
Kojima, D., Yamaguchi, S., Hashiguchi, A., Hayashi, K., Uchiyama, K., Yoshimoto, N., Adachi, K., Nakayama, T., Nishioka, K., Tajima, T., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.1037032 · Cited by 1
Maladies de Castleman : épidémiologie, classification et critères diagnostiques
Bertinchamp, R., & Terriou, L. (2022) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(23)00019-x · Cited by 1
A Googly in the Neck—Castleman Disease
Sheth, R. K., Kumar, P., Vishnurag, A., Choudhary, D., & Pushparaj, J. (2023) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-023-04266-3 · Cited by 1
A Case of Thrombocytopenia, Anasarca (Edema, Pleural Effusion, and Ascites), Fever, Reticulin Fibrosis/Renal Dysfunction, and Organomegaly (TAFRO) Syndrome Initially Not Presenting With Thrombocytopenia: A Role of Immature Platelet Fraction
Kanda, M., Kitamura, K., Saito, A., Hayashi, K., & Suzuki, T. (2024) · Cureus · doi:10.7759/cureus.58772 · Cited by 1
Self-citation
Recurrent Cerebral Hemorrhaging with Platelet Dysfunction Accompanied by Anti-glycoprotein VI Autoantibodies in a Patient with TAFRO Syndrome
Yamamoto, A., Nishimori, H., Shirai, T., Takano, K., Komura, A., Kambara, Y., Fukumi, T., Urata, T., Asada, N., Ennishi, D., et al. (2024) · Internal Medicine · doi:10.2169/internalmedicine.2799-23 · Cited by 1
Comparison of pathophysiological differences in TAFRO syndrome with or without lymphadenopathy
Uchiyama, T., Yokoyama, A., Kuroda, Y., & Aoki, S. (2024) · Journal of Clinical and Experimental Hematopathology · doi:10.3960/jslrt.24026 · Cited by 1
Idiopathic multicentric Castleman disease-TAFRO after COVID-19: A case report
Shiina, T., Yamamoto, E. K., Yamada, H., Sendo, S., Kanzawa, M., & Saegusa, J. (2024) · Modern Rheumatology Case Reports · doi:10.1093/mrcr/rxae045 · Cited by 1
Successful Treatment of TAFRO (Thrombocytopenia, Anasarca, Fever, Renal Insufficiency, and Organomegaly) Syndrome With Triple Combination Therapy of Corticosteroid, Tocilizumab, and Cyclosporine: A Case Report
Morino, J., Hirai, K., Yoshida, K., Kako, S., Ookawara, S., Oshiro, H., Sugawara, H., & Morishita, Y. (2025) · Cureus · doi:10.7759/cureus.80274 · Cited by 1
Morphological and quantitative CT features of anterior mediastinal lesions in TAFRO syndrome and idiopathic multicentric Castleman disease
Mohamed, L., Umeda, M., Tsutsui, S., Toya, R., Umetsu, A., Otsuka, M., Endo, Y., Shimizu, T., Fukui, S., Sumiyoshi, R., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1656489 · Cited by 1
Therapeutic outlook for Castleman’s disease: prospects for the next decade
Koga, T., Fujimoto, S., Kawakami, A., Kawabata, H., Masaki, Y., Kishimoto, T., & Yoshizaki, K. (2017) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2017.1348295 · Cited by 1
A case of Castleman disease that improved after kidney transplantation
Lee, H. R., An, J., Lee, D. R., Choi, H. W., Oh, J. S., & Kim, J. K. (2019) · Korean Journal of Transplantation · doi:10.4285/jkstn.2019.33.1.13 · Cited by 1
A Patient With Human Herpesvirus 8-Positive Multicentric Castleman’s Disease Who Met Criteria for TAFRO Syndrome: Controversy in Practice?
Fuentes-Lacouture, M. C., Gómez, C. C., Romero, M. L., Borda, A. A., Noreña, I., & Naranjo, J. A. (2020) · Journal of Medical Cases · doi:10.14740/jmc3523 · Cited by 1
TAFRO syndrome mimicking systemic lupus erythematosus: Case report and literature review
Puerta, G., Paz, D., Aguirre-Valencia, D. A., Ahumada, F. E., Silva, N., Bravo, J. C., & Echeverri, A. (2021) · Revista Colombiana de Reumatología · doi:10.1016/j.rcreu.2021.01.005 · Cited by 1
Hematopathology
Piña‐Oviedo, S., Khogeer, H. A., Tang, G., & Miranda, R. N. (2020) · Springer eBooks · doi:10.1007/978-3-319-96681-6_17 · Cited by 2
Storming the castle: A case report of multi‐system dysregulation in a child with Castleman disease
DeMarsh, S. J., Kendel, N. E., Bacha, C., Ardoin, S. P., Kahwash, S. B., & Rose, M. J. (2022) · Clinical Case Reports · doi:10.1002/ccr3.5491 · Cited by 1
Letter to the editor regarding ‘Non-cirrhotic portal hypertension associated with multicentric Castleman's disease: a case report’
Kobrin, D. M., Pinto, A. L., Parente, S. A. T., Gomes, M., Cipriano, M. A., Ribeiro, M. L., & Fajgenbaum, D. C. (2019) · Acta Oncologica · doi:10.1080/0284186x.2019.1574980 · Cited by 1
Self-citation
Successful Treatment of Immunosuppressant-resistant Thrombocytopeniawith Eltrombopag in a Patient with TAFRO Syndrome
Yoshiki, Y., Isotani, Y., Ishida, T., Sato, K., Suzuki, K., Miyazaki, K., Okazuka, K., Abe, Y., & Tsukada, N. (2017) · Journal of Blood Disorders & Transfusion · doi:10.4172/2155-9864.1000393
A case of TAFRO syndrome successfully treated with cyclosporin A and tocilizumab
Asano, T., Yashiro, M., Watanabe, A., Sato, S., Kobayashi, H., Watanabe, H., Ohkawara, H., Murakami, F., Hashimoto, Y., Koga, T., et al. (2017) · Modern Rheumatology Case Reports · doi:10.1080/24725625.2017.1413930
Une affreuse thymie pas typique
Outh, R., Fayard, D., Aumaître, O., André, M.-H., Aubart, F. C., & Lhote, R. (2018) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2018.07.002
Castleman’s Disease with All Aspects: Single Center Experience with Long Term Follow-up
Atilla, F., Demir, D., Soyer, N., Tombuloǧlu, M., Vural, F., Töbü, M., Şahin, F., Özsan, N., Hekimgil, M., & Saydam, G. (2018) · LLM Dergi · doi:10.5578/llm.66759
Accro à la dispense de sport jusqu’à une certaine séance de natation…
Humbert, S., Razanamahery, J., Payet-Revest, C., MÉAUX-RUAULT, N., Gil, H., Magy-Bertrand, N., & London, J. (2019) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2019.05.002
Benign Hematopoietic Disorders of the Mediastinum
Piña‐Oviedo, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-36438-0_27
Recurrent episodes of renal impairment with cytopaenias and lymphadenopathy
Swift, O., White, W. E., Bardsley, V., Proctor, I., & Thompson, B. E. (2021) · British Journal of Hospital Medicine · doi:10.12968/hmed.2020.0447
Morbus Castleman – ein seltenes, heterogenes Krankheitsbild
Hoffmann, C., Tepel, J., & Tiemann, M. (2021) · best practice onkologie · doi:10.1007/s11654-021-00300-4
Lymph Nodes
Geyer, J. T., & Orazi, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-66165-2.00014-4
Abnormal Exacerbation of Moderately Differentiated Gastric Adenocarcinoma in a Patient with TAFRO Syndrome: An Impaired Tumor Immunity?
Inano, T., Yasuda, H., Tsukune, Y., Tsutsui, M., Wali, N., Saeki, H., Kajino, K., Hino, O., Masaki, Y., & Komatsu, N. (2022) · Case Reports in Oncology · doi:10.1159/000521463
A Severe Case of Tafro Syndrome With myocardial and Skeletal Muscle calcification Despite Hypocalcemia: A Case ReportPreprint
Minomo, S., Fujiwara, Y., Sakashita, S., Takamura, A., & Nagata, K. (2020) · doi:10.21203/rs.3.rs-38754/v1
Castleman Disease
Kobrin, D. M., & Fajgenbaum, D. (2019) · Periodic and Non-Periodic Fevers · doi:10.1007/978-3-030-19055-2_11
Self-citation
Last Resort
Zipursky, J. S., Holmes‐Maybank, K. T., Shumak, S. L., & Duckett, A. A. (2019) · Journal of Hospital Medicine · doi:10.12788/jhm.3223
Tumorartige Lymphadenopathien
Müller‐Hermelink, H. K., & Rüdiger, T. (2018) · Springer eBooks · doi:10.1007/978-3-540-85184-4_19
A case report of TAFRO syndrome diagnosed with a previously undiagnosed mediastinal tumor
Sato, T., Ueda, T., Sakuma, A., Sato, T., Mayumi, K., Tamai, K., & Takahashi, H. (2022) · Journal of the Japanese Society of Intensive Care Medicine · doi:10.3918/jsicm.29_285
Chasing My Cure: Lessons Learned from My Rare Illness
Fajgenbaum, D. C. (2022) · Springer eBooks · doi:10.1007/978-3-031-04935-4_1
Self-citation
Castlemans Disease – Presenting with Recurrent Pleuropericardial Effusions- Mimicking Tuberculosis
(2023) · International Journal of Case Reports · doi:10.28933/ijcr-2022-12-2805ia
A case of TAFRO syndrome in which differentiation from hepatic ascites was important because of hepatitis C virus infection
Iwata, H., Hashiguchi, M., Tamai, T., Tashima, S., Muromachi, K., IWASHITA, Y., Nasu, Y., Hori, T., Tsubouchi, H., & Ido, A. (2023) · Choonpa Igaku · doi:10.3179/jjmu.jjmu.a.231
TAFRO syndrome mimicking systemic lupus erythematosus: Case report and literature review
Puerta, G., Paz, D. D., Aguirre-Valencia, D. A., Ahumada, F. E., Silva, N., Bravo, J. C., & Echeverri, A. (2022) · Revista Colombiana de Reumatología (English Edition) · doi:10.1016/j.rcreue.2021.01.006
Multicentric vs. Unresectable Unicentric Castleman Disease with Active Presentation: An Orphan Rare Disease in a Young Egyptian Female Patient. A Case Report
Shaaban, Y., El‐Ashwah, S., Elshamy, A., Atef, M., Saafan, M., Eladl, A. E., El-Sherpiny, S., R.Hendawy, S., Elbogdady, A., Elbogdady, M., et al. (2023) · Research in Oncology · doi:10.21608/resoncol.2023.179779.1187
Mediastinal Lymphoproliferative Disorders
Piña‐Oviedo, S., & Strange, C. D. (2023) · Springer eBooks · doi:10.1007/978-3-031-21040-2_8
TAFRO Syndrome, An Uncommon Presentation in a Pediatric PatientPreprint
Walker, A., Saad, S., Sangappa, S., Rao, H., Bhatla, T., & Batra, S. (2023) · doi:10.22541/au.168963103.32235081/v1
TAFRO syndrome associated with C3 nephropathy (an analysis of clinical experience)
Пожаров, И. В., Григоревская, А. О., Setdikova, G. R., & Stolyarevich, E. S. (2024) · The Clinician · doi:10.17650/1818-8338-2023-17-3-k697
Hemolytic uremic syndrome as a rare complication in a case of Castleman disease
Hsu, A. D., Ricoy, G. N., Savell, V., Becker, A. M., & Nhlane, N. (2024) · Pediatric Blood & Cancer · doi:10.1002/pbc.30969
Epstein–Barr virus-encoded RNA-positive lymphocytes in bone marrow and lymph nodes in an autopsy case of TAFRO syndrome
Tsugita, N., Miyagawa, I., Nakayamada, S., Nawata, A., Kosaka, S., Ueno, M., & Tanaka, Y. (2024) · Modern Rheumatology Case Reports · doi:10.1093/mrcr/rxae049
Systemic inflammatory disorders of the lymphoreticular system mimicking lymphoma: A focused group study
Chauhan, K., Kathuria, K., & Hatwal, V. (2024) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_279_23
A 57-year-old woman with unexplained refractory shock
Gómez, D. S., de Lacalle, A. L., Martino, B. N., & Bello, D. B. (2025) · Internal and Emergency Medicine · doi:10.1007/s11739-025-03865-y
A 31-Year-Old Pregnant Woman with Fever, Acute Kidney Injury, Hypervolemia, and Lymphadenopathy
O’Laughlin, A. E., Baratam, P., Budisavljevic, M. N., & Menon, A. A. (2025) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202406-571cc
Successful Treatment of Refractory TAFRO Syndrome with Cyclophosphamide: A Report of Two Cases
Nakamura, K., Miki, K., Ota, S., & Hoshi, T. (2025) · Internal Medicine · doi:10.2169/internalmedicine.4884-24
Clinical Utility of an Increased Pretreatment Immature Platelet Fraction in the Early Diagnosis of TAFRO Syndrome, Especially in Patients with Late-onset Thrombocytopenia: A Case Series and Literature Review
Saga, T., Kanagawa, M., Harada, T., & Ishihara, T. (2025) · Internal Medicine · doi:10.2169/internalmedicine.5006-24
Rapidly Progressive Joint Destruction in Idiopathic Multicentric Castleman’s Disease: A Case Report
Matsumoto, H., Matsuoka, N., Tasaki, K., Sato, N., Kuroda, M., & Miyata, M. (2025) · Cureus · doi:10.7759/cureus.85108
Multicentric Castleman disease presenting with orbital involvement progressing to TAFRO syndrome: a case report
Wei, Y.-F., Qi, J., Yan, J., Gao, G., Ji, X., Yu, D., Chen, W., & Huang, D. (2025) · BMC Ophthalmology · doi:10.1186/s12886-025-04251-0
So diagnostiziere ich den Morbus Castleman
Hoffmann, C. (2025) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-025-01681-5
Anterior mediastinal lesions in TAFRO syndrome: potential clinical significance
Ueda, Y., Shida, Y., Takamasu, E., Onishi, K., Miyoshi, Y., Nagai, Y., Shimada, K., Matsuda, S., Takamori, M., Kozai, Y., et al. (2025) · Rheumatology · doi:10.1093/rheumatology/keaf541
The heterogeneity of thoracic Castleman disease: implications for classification and personalized management
Zheng, Y., Zhu, J., Jiang, J., Ge, X., Liu, J., Jiang, W., Wang, Q., Zheng, W., Wang, S., & Ding, J. (2025) · Annals of Hematology · doi:10.1007/s00277-025-06685-4
Polyarteritis nodosa presenting with TAFRO signs following COVID-19 infection: case report
Ishigame, R., Iwata, S., Tabata, K., Kita, H., Nakashima, Y., Nakatsuka, M., Tabata, S., Iwamoto, R., Jinnin, M., Araki, S., et al. (2025) · Modern Rheumatology Case Reports · doi:10.1093/mrcr/rxaf075
Echocardiography-Guided Repositioning of a Hemodialysis Catheter in a Patient With Persistent Left Superior Vena Cava: A Case Report
Nozaki, Y., Kinoshita, J., & Miyake, K. (2026) · Cureus · doi:10.7759/cureus.101971
The value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis and evaluation of TAFRO syndrome: a review of cases and literature
Xian, H., Gao, Y., Guan, Y., Wang, G., & Su, X. (2026) · Clinical Radiology · doi:10.1016/j.crad.2026.107272
Autoimmune and Immune-Mediated Conditions
(2026) · American Registry of PathologyArlington, Virginia eBooks · doi:10.55418/9781933477664-06
Destructive Thyrotoxicosis and Annular Erythema, as an Initial Presentation of Idiopathic Multicentric Castleman Disease with TAFRO Symptoms (IMCD-TAFRO): An Autopsy Case Study
Yoshino, K., Nishibori, K., Nagashima, K., Kuroda, H., Shirato, S., Ibuki, S., Kiuchi, S., & Kanisawa, Y. (2025) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.114.237
Sarcoma de Kaposi y enfermedad de Castleman multicéntrica asociados a infección por HVH-8 en un paciente con infección por el VIH
Téllez, M. A. V., Cely, H. C. P., & Franco, O. A. (2026) · Piel · doi:10.1016/j.piel.2025.09.014
Elucidating the grading intricacies of idiopathic multicentric Castleman disease histopathology: a pathologist’s perspective
Alapat, D. V., Etebari, P., & van Rhee, F. (2025) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaf134
Castleman Disease
Sivaramakrishnan, P. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1009424
Nouvelles immunothérapies dans le traitement du syndrome de Sjögren et autres maladies interféron-dépendantes
Killian, M. (2019) · theses.fr (ABES) · doi:10.70675/149672f6zd66az455ezaf8dz5befec5c0dc5
Morphological characteristics of the renal lesion in TAFRO syndrome and POEMS syndrome: a retrospective and multicenter study
Masuzawa, N., Ono, Y., Kakita, H., Yumura, W., Hashiguchi, A., Kawanishi, K., Azegami, T., Uesugi, N., Muso, E., Ueda, Y., et al. (2026) · Clinical and Experimental Nephrology · doi:10.1007/s10157-026-02864-3
A Case of TAFRO (Thrombocytopenia, Anasarca, Fever or Fibrosis of the Bone Marrow, Renal Dysfunction, and Organomegaly): Exploring the Idiopathic Variant of Multicentric Castleman Disease
Parasu, T., Gaddam, N., Ahmed, T. R., Parasu, A., & Palanisamy, N. (2026) · Cureus · doi:10.7759/cureus.107204
Bilateral Ground-Glass Opacities as an Initial Manifestation of iMCD-TAFRO Syndrome: Diagnostic Insights from a Case with Negative Lung Biopsy Findings
Kami, W., Baba, M., Yamaniha, K., Gaja, S., Chinen, T., Yamamoto, K., & Fujita, J. (2026) · Internal Medicine · doi:10.2169/internalmedicine.7113-26
A Case of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Dysfunction, and Organomegaly (TAFRO) Syndrome Refractory to Treatment With Combination Therapy of Corticosteroid, Tocilizumab, and Rituximab: A Case Report
Ogawa, A., & Yamaguchi, K. (2026) · Cureus · doi:10.7759/cureus.110337
Successful treatment of idiopathic multicentric Castleman disease with TAFRO and kidney involvement: case report and literature review
Kamal, A., Doppalapudi, H. B., Ho, T., Vilayet, S., Pasham, V., Budisavljevic, M. N., & Achanti, A. (2026) · Renal Failure · doi:10.1080/0886022x.2026.2671463
Idiopathischer multizentrischer Morbus Castleman als differenzialdiagnostische Herausforderung
Pavol, P., Szemanova, E., Rubbert‐Roth, A., & Wolfrum, S. (2026) · Rheuma Plus / Schweiz · doi:10.1007/s44332-026-00126-8
Treating Castleman disease: insights into the use and efficacy of monoclonal antibodies
Nishimura, Y., Habermann, T. M., Dispenzieri, A. A., & van Rhee, F. (2026) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2026.2702010
Diagnostic delay and histopathological subtyping challenges in idiopathic multicentric Castleman disease, not otherwise specified: a case report of a three-hospital odyssey
Zhang, F., Wang, N., Wang, Y.-Y., Ye, P., Bao, Y.-C., Shi, H.-Z., Qian-wen, X., Zhang, X., Wang, X.-X., Liao, C.-M., et al. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1829540
Síndrome Trombocitopenia, Anasarca, Fiebre, Fibrosis Reticulínica y Organomegalia (TAFRO) como subtipo distintivo de la enfermedad de Castleman multicéntrica idiopática: reporte de caso
Gaona, J. O. P., Spirko, P., Alfonso, S. I. L., & Romero, G. I. T. (2026) · Arandu-UTIC. · doi:10.69639/arandu.v13i2.2409
Neural Epidermal Growth Factor-Like 1-Associated Membranous Nephropathy in a Patient With Thrombocytopenia, Anasarca, Fever, Renal Dysfunction, and Organomegaly (TAFRO Syndrome): A Case Report
Yamakawa, M., Katayama, K., Sakai, Y., Matsui, Y., Mori, M., Yamawaki, M., Saiki, R., Murata, T., & Dohi, K. (2026) · Kidney International Case Reports · doi:10.1016/j.kintcr.2026.100140
Clusterin expression and germinal center morphometry help distinguish idiopathic multicentric castleman disease from select lymphadenopathies
Gonzalez, M. V., Wang, K., Zinski, J. M., Mumau, M. D., Forsyth, K. S., Irvine, A. H., Brandstadter, J. D., Guzman, S. G., Zhang, L., Pierson, S. K., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1872505
Self-citation
Castleman Disease: Unraveling Diagnostic Challenges Through Clinical and Pathologic Perspectives
Saha, A., Sokol, L., & Zhang, L. (2026) · European Journal Of Haematology · doi:10.1111/ejh.70298
Rethinking Common Diagnoses: Idiopathic Multicentric Castleman Disease Presenting as TAFRO Syndrome: A Case Report
Rohatgi, D., Chakraborty, A., Kumar, S., & Rohatgi, A. (2026) · Clinical Case Reports · doi:10.1002/ccr3.73663
Systemic Lupus Erythematosus-Associated Autoimmune Myelofibrosis Mimicking TAFRO Syndrome: A Case Report and Literature Review
Lodha, N., Jain, A., Kummara, J., Yadav, N., & Sreedharanunni, S. (2026) · Cureus · doi:10.7759/cureus.118256
Sjögren’s disease complicated by TAFRO syndrome: a case report of fever and lymphadenopathy with literature review
Han, Y., Xu, X., Gu, Q., Xu, C., Shen, N., & Wang, X. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1947691

Authors: Iwaki, N., Fajgenbaum, D. C., Nabel, C. S., Gion, Y., Kondo, E., Kawano, M., Masunari, T., Yoshida, I., Moro, H., Nikkuni, K., Takai, K., Matsue, K., Kurosawa, M., Hagihara, M., Saito, A., Okamoto, M., Yokota, K., Hiraiwa, S., Nakamura, N., Nakao, S., Yoshino, T., & Sato, Y.
Affiliations: Kanazawa University (JP)
University of Pennsylvania (US)
Okayama University (JP)
Kanazawa University Hospital (JP)
Chugoku Central Hospital (JP)
Shikoku Cancer Center (JP)
Niigata University (JP)
Niigata City General Hospital (JP)
Kameda Medical Center (JP)
Sapporo National Hospital (JP)
Eiju General Hospital (JP)
National Hospital Organization (JP)
Fujita Health University (JP)
Tokai University (JP)
Corresponding author: Sato, Yasuharu
ORCID: Fajgenbaum, David C.
Nabel, Christopher S.
Gion, Yuka
Kondo, Eisei
Kawano, Mitsuhiro
Masunari, Taro
Yoshida, Isao
Moro, Hiroshi
Matsue, Kosei
Hagihara, Masao
Yokota, Kenji
Hiraiwa, Shinichiro
Nakamura, Naoya
Nakao, Shinji
Sato, Yasuharu
Venue: American Journal of Hematology
Publisher: Wiley
Published: 2016-01-22
Volume: 91
Issue: 2
Pages: 220-226
ISSN: 0361-8609 (ISSN-L)
1096-8652
DOI: 10.1002/ajh.24242
OpenAlex: W2179940598
Cited by: 296
References: 39
Citations by year: 2026: 28 · 2025: 30 · 2024: 30 · 2023: 19 · 2022: 31 · 2021: 29 · 2020: 34 · 2019: 23 · 2018: 34 · 2017: 30 · 2016: 7
FWCI: 10.48
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: American Journal of Hematology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphadenopathy Diagnosis and Analysis
Keywords: TAFRO syndrome, multicentric Castleman disease, idiopathic multicentric Castleman disease, thrombocytopenia, anasarca, fever, reticulin fibrosis, organomegaly, cytokine storm, lymph node histopathology, endothelial cell proliferation, corticosteroid therapy, acute kidney injury, hypergammaglobulinemia
MeSH terms: Adult, Aged, Female, Castleman Disease, Humans, Lymph Nodes, Male, Middle Aged, Plasma Cells, Platelet Count, Syndrome, Thrombocytopenia, Herpesvirus 8, Human, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV ‐8‐negative multicentric Castleman disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks